Medicine and Dentistry
Patient
100%
Donor
42%
Syndrome
37%
Prognosis
37%
Myelodysplastic Syndrome
37%
Vein Occlusion
37%
Donor Lymphocyte Infusion
37%
Chronic Myelomonocytic Leukemia
37%
Chromosome 5
37%
Experience
37%
Liver Venoocclusive Disease
31%
Therapeutic Procedure
18%
Protein P53
18%
Adult
18%
Mutant
18%
Hazard Ratio
15%
Diagnosis
12%
Transplantation
10%
Single Nucleotide Polymorphism
9%
Gene
9%
International Prognostic Scoring System
9%
Follow up
9%
Myeloid Malignancy
9%
Age
9%
Adjustment
9%
Incidence
9%
Protein Expression
9%
Azacitidine
9%
Overall Survival
9%
T Cell
8%
Therapeutics
8%
Hematological Cancer
6%
Analysis
6%
Complication
6%
Biochemistry, Genetics and Molecular Biology
Cytogenetics
56%
Stem Cell
37%
Single-Nucleotide Polymorphism
9%
Gene
9%
Spectrum
9%
Wild Type
9%
Karyotyping
9%
Reduction (Chemistry)
9%
T Cell Receptor
6%
